Bank of Montreal’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bank of Montreal’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.01M	Buy	+38,400	New	+$1.12M	﹤0.01%	2031
2022 Q3	–	Sell	-25,000	Closed	-$856	–	4064
2022 Q2	$856	Hold	25,000	–	–	﹤0.01%	2407
2022 Q1	$1.24M	Hold	25,000	–	–	﹤0.01%	2201
2021 Q4	$1.57M	Buy	+25,000	New	+$1.73M	﹤0.01%	1703
2021 Q1	–	Sell	-15,000	Closed	-$1.57M	–	5052
2020 Q4	$1.57M	Buy	+15,000	New	+$1.2M	﹤0.01%	1958

Other funds holding ARKG

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Bank of Montreal's ARKG Position: Q1 2026 in Review

Bank of Montreal reduced its ARK Genomic Revolution ETF (ARKG) stake by 72% in Q1 2026, selling an estimated $327K and leaving 4,377 shares worth $116K. The position accounts for ﹤0.01% of the portfolio, ranked #3095.

Bank of Montreal first reported a position in ARKG in Q1 2018 and has held it in 33 quarters since. The position peaked at $2.72M in Q4 2020. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

Bank of Montreal held 4,377 shares of ARK Genomic Revolution ETF worth $116K as of Q1 2026.
Bank of Montreal sold 11,158 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $327K.
ARK Genomic Revolution ETF made up ﹤0.01% of Bank of Montreal's portfolio in Q1 2026, its #3095 holding.
Bank of Montreal first reported a position in ARK Genomic Revolution ETF in Q1 2018 and has held it in 33 quarters since.
Bank of Montreal's ARK Genomic Revolution ETF position peaked at $2.72M in Q4 2020.
218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.